PRMT1 Inhibition Activates the Interferon Pathway to Potentiate Antitumor Immunity and Enhance Checkpoint Blockade Efficacy in Melanoma.

Tao H, Jin C, Zhou L, Deng Z, Li X, Dang W, Fan S, Li B, Ye F, Lu J, Kong X, Liu C, Luo C, Zhang Y
Cancer Res. 2024 Feb 1;84(3):419-433. doi: 10.1158/0008-5472.CAN-23-1082. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.